David has over 20 years’ experience designing and delivering primary research solutions for strategic insights in the healthcare industry.

He has a background in chemistry and management from Imperial College London. He enjoyed a brief spell with Novartis in Basel, assisting in lead synthesis of novel molecules for their pharmaceutical pipeline. He was lucky enough to work with some of the team who developed the cancer treatment imatinib, and in the same building where LSD was first synthesized.

Since then, David has committed his career to helping pharmaceutical clients traverse the challenging terrain of pipeline to launch and beyond, by providing insights to resolve their challenging commercial and clinical questions.

He has a special interest in clever research design and pushing the envelope of insights practice via innovative methodologies to help bring clients closer to the reality of clinical practice.

Barry has over 25 years’ experience in global pharma insights, encompassing exploratory, qualitative methodologies through to statistical quantitative solutions.

Barry studied Psychology at Middlesex University in London, during which time he worked briefly at Great Ormond Street Hospital as an auxiliary nurse in the mental health unit, before embarking on his Insights career.

He has conducted research in most major therapy areas but with specific expertise in haematology, oncology, ophthalmology, and neuroscience.

His experience spans the project life cycle, from early asset opportunity assessment and scenario planning, through customer segmentation, positioning, and communications.

Barry strives to bring clarity and direction to client challenges, irrespective of their complexity.

Ann-Marie holds a degree in Biology. She began her career at GSK, working in their data science team.

Since transitioning into pharmaceutical market research 10 years ago, she has built wide-ranging expertise throughout the product life cycle from early pipeline exploration all the way through to postlaunch optimisation.

With her science background, Ann-Marie thrives on the complexity that underpins meaningful insights, bringing a structured and analytical approach to her research.

She has a passion for translating complex evidence into clear, actionable direction. She is committed to helping clients navigate key commercial and clinical challenges with confidence and ease.

Melissa began her research career in academic behavioural science, having specialised in Cognitive Neuroscience. During her time in academia, she worked alongside the team who were responsible for the discovery and development of Epidyolex (cannabidiol) as a treatment in rare developmental and epileptic encephalopathies.

Since joining Porterhouse Insights in 2019, she has delivered insights in a vast array of disease areas but has special interest in rare diseases and neuroscience.

Melissa is eager to bring innovation to market research, often drawing upon behavioural science evidence. This passion for innovation and ‘all things behaviour’ led her to found team ‘Optimise,’ Porterhouse Insights’ behavioural science group.

Melissa is led by one principle: meaningful, actionable, and clear insights come from understanding people, not just data.

Lauren brings over a decade of experience in pharmaceutical market research, working across a wide range of therapy areas with particular depth in immunology and neuroscience.

She began her career at Research Partnership before moving to Prescient, where she established a quantitative research team and led global mixed‑methodology programmes. Her strength lies in transforming complex data into clear, strategic insights that support confident decision‑making.

Now at Porterhouse Insights, Lauren applies that experience, and a focus on designing research shaped by the challenge rather than convention, to address the core of each client issue.

She focuses on uncovering actionable truths and ensuring that findings resonate across cross‑functional teams, creating alignment and momentum for the clients she supports.

Alice holds a degree in Psychology and brings a strong interest in how insights support healthcare decision‑making. She has significant expertise in infectious disease, rare disease, and neurology, contributing to research that helps clients address complex commercial and clinical questions.

At Porterhouse Insights, Alice works on research programmes designed to provide clear direction and practical perspectives. She is motivated by research that draws on behavioural economics to bring perspective to ambiguity. She helps clients understand real‑world decision‑making to make informed and confident commercial choices.